Antigen-binding molecules that bind CD38 and/or CD28, and uses thereof
US-12590168-B2 · Mar 31, 2026 · US
This page is not indexed by search engines while we improve data quality.
Dilillo David patents
Dilillo David is listed as an inventor on 24 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Dilillo David |
| Total patents | 24 |
| First publication | Jan 23, 2020 |
| Latest publication | Mar 31, 2026 |
Notable patents
Publications ranked by popularity score, then publication date.
GPRC5D x CD28 Bispecific Antibodies and Methods of Use Thereof
US-2026014252-A1 · Jan 15, 2026 · US
Bispecific Anti-BCMA x Anti-CD3 Antibodies and Uses Thereof
US-2026008862-A1 · Jan 8, 2026 · US
Compositions and methods for treating cancer
US-2025223334-A1 · Jul 10, 2025 · US
Compositions and methods for treating cancer
US-12291559-B2 · May 6, 2025 · US
Nucleic acid molecules encoding bispecific anti-BCMA x anti-CD3 antibodies
US-12258412-B2 · Mar 25, 2025 · US
Muc16 chimeric antigen receptors
US-2025082756-A1 · Mar 13, 2025 · US
Chimeric antigen receptors with BCMA specificity and uses thereof
US-12150959-B2 · Nov 26, 2024 · US
Chimeric Antigen Receptors with BCMA Specificity and Uses Thereof
US-2024325445-A1 · Oct 3, 2024 · US
Chimeric Antigen Receptors with MAGE-A4 Specificity and Uses Thereof
US-2024226163-A1 · Jul 11, 2024 · US
Recent patents
Latest publications not already listed above.
Compositions and methods for treating cancer
US-2024165157-A1 · May 23, 2024 · US
Antigen-binding molecules that bind cd38 and/or cd28, and uses thereof
US-2024158529-A1 · May 16, 2024 · US
Methods of treating cancer with a combination of adoptive cell therapy and a targeted immunocytokine
US-2024148867-A1 · May 9, 2024 · US
Antigen-binding molecules that bind CD38 and/or CD28, and uses thereof
US-11905332-B2 · Feb 20, 2024 · US
Multispecific antigen binding molecules that bind cd38 and 4-1bb, and uses thereof
US-2023416396-A1 · Dec 28, 2023 · US
Compositions and methods for treating cancer
US-11826386-B2 · Nov 28, 2023 · US
Bispecific Anti-BCMA x Anti-CD3 Antibodies and Uses Thereof
US-2022306758-A1 · Sep 29, 2022 · US
Chimeric Antigen Receptors with MAGE-A4 Specificity and Uses Thereof
US-2022281994-A1 · Sep 8, 2022 · US
Anti-new york esophageal squamous cell carcinoma 1 (ny-eso-1) antigen-binding proteins and methods of use thereof
US-2022251215-A1 · Aug 11, 2022 · US
Bispecific anti-BCMA x anti-CD3 antibodies and uses thereof
US-11384153-B2 · Jul 12, 2022 · US
Antigen-binding molecules that bind cd38 and/or cd28, and uses thereof
US-2022089766-A1 · Mar 24, 2022 · US
Compositions and methods for treating cancer
US-2022031748-A1 · Feb 3, 2022 · US
Bispecific Anti-BCMA x Anti-CD3 Antibodies and Uses Thereof
US-2020024356-A1 · Jan 23, 2020 · US
Chimeric Antigen Receptors with BCMA Specificity and Uses Thereof
US-2020023010-A1 · Jan 23, 2020 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Regeneron Pharma | 24 |
| Regeneran Pharmaceuticals Inc | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P35/00 | 21 |
| A61K40/11 | 18 |
| C07K2317/565 | 16 |
| A61K2239/38 | 16 |
| C07K2317/73 | 16 |